Back to search

Peptide record

TPDB41337

P03 Anticancer standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41337
P03
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 13-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
HVFGESDELIGQK
Physicochemical Analysis
C64H99N17O22
ARNCMPTWY
EG
1458.59
4.42
2
3
4
-2
6.02
-0.569
82.31
Mammalian: 3.5 hour Yeast: 10 min E.coli: >10 hour
0
0.00
2
Residue Composition
number
0
A
0
R
0
N
1
D
0
C
2
E
1
Q
2
G
1
H
1
I
1
L
1
K
0
M
1
F
0
P
1
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 1 C: 0 E: 2 Q: 1 G: 2 H: 1 I: 1 L: 1 K: 1 M: 0 F: 1 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
13
C64H99N17O22
1458.59
4.42
-2
6.02
-0.569
Free
L
Linear
Free
Anticancer
Triosephosphate Isomerase (TPI) fragment
Evidence Records 2 records
Evidence 1 Activity

Activity

Relative viability
Relative viability = 1.04 at 50 µg/ml
Anticancer

Target

Bone Cancer
MG-63
Bone

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

Relative viability
Relative viability = 0.98 at 50 µg/ml
Anticancer

Target

Bone Cancer
U-2 OS
Bone

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023